Adverse reactions of Balversa

The most common (>20%) adverse reactions, including laboratory  abnormalities, were increased phosphate, nail disorders, stomatitis, diarrhea,  increased creatinine, increased alkaline phosphatase, increased alanine  aminotransferase, decreased hemoglobin, decreased sodium, increased  aspartate aminotransferase, fatigue, dry mouth, dry skin, decreased phosphate,  decreased appetite, dysgeusia, constipation, increased calcium, dry eye,  palmar-plantar erythrodysesthesia syndrome, increased potassium, alopecia,  and central serous retinopathy. 

from FDA,2024.01